Skip to main content
. 2024 Mar 18;15:1335441. doi: 10.3389/fphar.2024.1335441

TABLE 1.

Summary of CBD products tested based on product labeling a .

All products (N = 202) Tinctures (n = 100) Gummies (n = 48) Topicals (n = 20) Vape products (n = 34)
Full spectrum 84 50 18 10 6
Broad spectrum 28 14 9 4 1
CBD isolate products 37 12 6 2 17
Not specified b 53 24 15 4 10
Total 202 100 48 20 34
a

Full spectrum, broad spectrum, and CBD, isolate are based on claims made on the product packaging.

b

Products did not have a specific claim related to hemp content. CBD, cannabidiol.

HHS Vulnerability Disclosure